Press/Media
Michelson Diagnostics launches new improved version of VivoSight OCT scanner with Micro-Camera to aid skin cancer diagnosis
Orpington, UK, 8th October 2014 – Michelson Diagnostics, the UK based medical device company focused on multi-beam Optical Coherence Tomography (‘OCT’) technology, announces the launch of a new improved version of its innovative VivoSight OCT scanner at the European Academy of Dermatology and Venereology (EADV) Annual Meeting, 8-12 October, Amsterdam.
Click here to download a pdf copy of the article
Michelson Diagnostics to present at Fortbildungswoche, Munich
Orpington, UK, 18 July 2014 – Michelson Diagnostics, the UK based medical device company focused on multi-beam Optical Coherence Tomography (‘OCT’) technology, today announces that leading experts in the use of optical technology in dermatology will be presenting the benefits of multi-beam OCT at the 24th Annual Education Week for Practical Dermatology and Venereology, known as Fortbildungswoche, in Munich, Germany, 19-25 July 2014.
Click here to download a pdf copy of the article
Orpington, UK, 23 May 2014 – Michelson Diagnostics, the UK based medical device company focused on multi-beam Optical Coherence Tomography (‘OCT’) technology, has commenced a clinical study to investigate the use of OCT to diagnose basal cell carcinoma in collaboration with the Melanoma Institute of Australia using Michelson’s Diagnostics VivoSight system.
Click here to download a pdf copy of the article
Optical Coherence Tomography - Using light waves to tune into the market
Orpington, UK, 2 May 2014 – Michelson Diagnostics is featured in a brochure on the future of Photonics issued by the Photonics Knowledge Transfer Network (a government sponsored quango funded by the Technology Strategy Board).
Click here to read the article on pages 41-43 of the publication.
Positive top line results from clinical trial for diagnosis of basal cell carcinoma using VivoSight OCT
Orpington, UK, 26 March 2014 – Michelson Diagnostics, the UK based medical device company focused on multi-beam Optical Coherence Tomography (‘OCT’) technology, announces positive top line results from the successfully completed multi-centre, prospective clinical trial for the diagnosis of basal cell carcinoma using VivoSight OCT.
Click here to download the full press release in pdf format
Positive results from multi-centre, prospective clinical trial for diagnosis of basal cell carcinoma using Michelson Diagnostics’ VivoSight OCT Presented at AAD
Orpington, UK, 21 March 2014 – Michelson Diagnostics, the UK based medical device company focused on multi-beam Optical Coherence Tomography (‘OCT’) technology, today announces positive results from the successfully completed multi-centre, prospective clinical trial for the diagnosis of basal cell carcinoma using VivoSight OCT to be presented at the upcoming American Academy of Dermatology’s 72nd Annual Meeting (AAD) in Denver, Colorado, 21-25 March 2014.
Click here to download the full press release in pdf format
Michelson Diagnostics announces completion of data collection in Vivosight OCT trial for BCC diagnosis
Orpington, UK, 5th March 2014 – Michelson Diagnostics, the UK based medical device company focused on multi-beam Optical Coherence Tomography (‘OCT’) technology, today announces that it has completed scanning and data collection for a large 250-patient, multi-centre, prospective clinical trial of the diagnostic performance of its VivoSight™ OCT scanner in diagnosing superficial basal cell carcinoma (BCC), the most common form of skin cancer.
Click here to download the full press release in pdf format
Michelson Diagnostics to launch enhanced software for VivoSight OCT scanner
Orpington, UK, 14 February 2014 – Michelson Diagnostics, the UK based medical device company focused on multi-beam Optical Coherence Tomography (‘OCT’) technology, today announces the launch of its upgraded VivoSight OCT scanner with a new software technology that provides additional features for dermatologists to investigate skin lesions such as non-melanoma skin cancer.
Click here to download the full press release in pdf format
Axsun Technologies Announces Volume Purchase Order for Swept Laser Engines from Michelson Diagnostics Ltd
Orpington, UK, 4 February 2014 – Michelson Diagnostics, the UK based medical device company focused on multi-beam Optical Coherence Tomography (‘OCT’) technology, today notes Axsun Technologies announcement of the volume purchase order for Swept Laser Engines to be used in Michelson Diagnostics Vivosight Multi-Beam OCT system.
Click here to download the full press release in pdf format
Michelson Diagnostics targets malignant melanoma using OCT imaging with €2.3M EU funding
Orpington, UK, 16 January 2014 – Michelson Diagnostics, the UK based medical device company focused on multi-beam Optical Coherence Tomography (‘OCT’) technology, announces that the European Union has awarded a €2.26 million Framework 7 grant to a consortium of seven partners, towards the cost of a project targeting malignant melanoma with OCT imaging.
Click here to download the full press release in pdf format
Michelson Diagnostics Announces £1.98 Million Financing
Orpington, UK, 11 December 2013 – Michelson Diagnostics, the UK based medical device company focused on multi-beam Optical Coherence Tomography (‘OCT’) technology, is delighted to announce the first closing of its Series A2 Financing. The round, which was oversubscribed, raised £1.98 million ($3.25million) from existing investors, led by Octopus Investments and supported by Catapult Venture Managers Ltd and London Business Angels, and several business angels.
Click here to download the full press release in pdf format
